BOT

0.68%

37.3¢ botanix pharmaceuticals ltd

Always appreciate your efforts @aaragon...could you start a new...

First 222 Last

WBA

2,358 Posts.

417

20/06/24

16:38

Post #: 74411928

Originally posted by aaragon: ↑
I've been on heaps of Shares that have done CRs after pivotal announcements, and most of the time, they always go up.

Anyway, if the volume of shares goes from 1.5B to 1.7B, the market cap drops but if the shares go up, it will equal or better.
The long-term strategy looks awesome IMO. If Bot can make earnings of 2% not taking expenses into account, that brings the price to $5.48 with current shares on issue, or $4.87 with the additional 200 mill.

Anyway, even if I've stuffed this up to some degree. I'm pretty sure the long-term strategy is going ot be mega, so if an additional $60 mill is needed, that do it.
Before CR
1 Current Market Cap $527,700,000.00
2 Current Share price 0.335
3 Shares on Market 1,575,223,881
4

5 Patients needing treatment 16,000,000
6 Achievable market percentage 2%
7

8 Percentage of customers treated 320,000
9 Cost of goods (COG) $750.00
10 Months needing treatment 12
11

12 Gross Revenue $2,880,000,000.00
13 Exp NFI
14 Shares divided by Revenue $1.83
15 Growth Potential PE 3
16

17 Current price $5.48

After CR
1 Current Market Cap $527,700,000.00
2 Current Share price 0.30
3 Shares on Market 1,775,223,881
4

5 Patients needing treatment 16,000,000
6 Achievable market percentage 2%
7

8 Percentage of customers treated 320,000
9 Cost of goods (COG) $750.00
10 Months needing treatment 12
11

12 Gross Revenue $2,880,000,000.00
13 Exp NFI
14 Shares divided by Revenue $1.62
15 Growth Potential PE 3
16

17 Current price * Growth potential $4.87
Expand
Always appreciate your efforts @aaragon...could you start a new thread with this as first post....thank you in anticipation

BOT Price at posting: 33.5¢ Sentiment: None Disclosure: Held

10 Upvote

0 Great analysis

Top Stories

WAF

West African Res jumps on claim mine safe under Burkina Faso's junta; HotCopper ponders Russia

OCC

Orthocell wins first international approval for nerve repair product

TMK

TMK Energy kicks off drilling for new pilot wells in Mongolia's vastly underexplored Gobi

LMS

Litchfield boosts its copper, base and precious metals footprint in the NT with acquisitions

DRO

Droneshield shares move up on $13.5M US govt contract

There are more pages in this discussion • 333 more messages in this thread...

First 222 Last

Add BOT (ASX) to my watchlist

(20min delay)
Last 37.3¢		Change 0.003(0.68%)		Mkt cap ! $675.7M

Open	High	Low	Value	Volume
37.0¢	37.5¢	36.8¢	$839.4K	2.266M

Buyers (Bids)

No.	Vol.	Price($)
2	16326	39.0¢

Sellers (Offers)

Price($)	Vol.	No.
35.0¢	11880	4

View Market Depth

No.	Vol.	Price($)
1	11298	0.390
1	5028	0.385
2	75567	0.370
12	548226	0.365
14	230162	0.360

Price($)	Vol.	No.
0.375	49065	7
0.380	344070	10
0.385	175000	2
0.390	100550	3
0.395	151300	3

Last trade - 15.59pm 08/10/2024 (20 minute delay)

BOT (ASX) Chart

Always appreciate your efforts @aaragon...could you start a new...

West African Res jumps on claim mine safe under Burkina Faso's junta; HotCopper ponders Russia

Orthocell wins first international approval for nerve repair product

TMK Energy kicks off drilling for new pilot wells in Mongolia's vastly underexplored Gobi

Litchfield boosts its copper, base and precious metals footprint in the NT with acquisitions

Droneshield shares move up on $13.5M US govt contract

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

	Before CR
1	Current Market Cap	$527,700,000.00
2	Current Share price	0.335
3	Shares on Market	1,575,223,881
4
5	Patients needing treatment	16,000,000
6	Achievable market percentage	2%
7
8	Percentage of customers treated	320,000
9	Cost of goods (COG)	$750.00
10	Months needing treatment	12
11
12	Gross Revenue	$2,880,000,000.00
13	Exp	NFI
14	Shares divided by Revenue	$1.83
15	Growth Potential PE	3
16
17	Current price	$5.48

	After CR
1	Current Market Cap	$527,700,000.00
2	Current Share price	0.30
3	Shares on Market	1,775,223,881
4
5	Patients needing treatment	16,000,000
6	Achievable market percentage	2%
7
8	Percentage of customers treated	320,000
9	Cost of goods (COG)	$750.00
10	Months needing treatment	12
11
12	Gross Revenue	$2,880,000,000.00
13	Exp	NFI
14	Shares divided by Revenue	$1.62
15	Growth Potential PE	3
16
17	Current price * Growth potential	$4.87

Always appreciate your efforts @aaragon...could you start a new...

Top Stories

West African Res jumps on claim mine safe under Burkina Faso's junta; HotCopper ponders Russia

Orthocell wins first international approval for nerve repair product

TMK Energy kicks off drilling for new pilot wells in Mongolia's vastly underexplored Gobi

Litchfield boosts its copper, base and precious metals footprint in the NT with acquisitions

Droneshield shares move up on $13.5M US govt contract

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News